InvestorsObserver
×
News Home

AbbVie Inc (ABBV) has fallen -1.48% in a Week, Should You Sell?

Friday, January 14, 2022 01:03 PM | InvestorsObserver Analysts

Mentioned in this article

AbbVie Inc (ABBV) has fallen -1.48% in a Week, Should You Sell?

AbbVie Inc (ABBV) is near the top in its industry group according to InvestorsObserver. ABBV gets an overall rating of 70. That means it scores higher than 70 percent of stocks. AbbVie Inc gets a 90 rank in the Drug Manufacturers - General industry. Drug Manufacturers - General is number 69 out of 148 industries.

Overall Score - 70
ABBV has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on ABBV!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With AbbVie Inc Stock Today?

AbbVie Inc (ABBV) stock is trading at $132.89 as of 12:55 PM on Friday, Jan 14, a drop of -$0.63, or -0.47% from the previous closing price of $133.52. Volume today is light. So far 3,708,726 shares have traded compared to average volume of 6,983,017 shares. The stock has traded between $132.29 and $133.83 so far today. Click Here to get the full Stock Report for AbbVie Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App